
Electromed (ELMD) Stock Forecast & Price Target
Electromed (ELMD) Analyst Ratings
Bulls say
Electromed Inc. reported a substantial growth in homecare revenue, which increased by 14.8%, reaching $14.1 million, driven by enhanced sales rep productivity and effective demand generation strategies. The company demonstrated significant expansion in its market presence, with notable increases in distributor sales by 41% and hospital sales by 52%, indicating robust demand for its airway clearance products. Furthermore, the rise in SG&A expenses by 17.2% reflects Electromed's strategic investments in scaling its operations, positioning the company well for continued growth in the homecare and acute care sectors.
Bears say
Electromed Inc. faces a challenging financial outlook due to several fundamental issues, including margin compression, increasing competitive pressures, and diminished sales representative productivity, which may hinder revenue growth. Additionally, potential delays in the company's growth drivers for Pain Management and Wound Care could further adversely impact expected growth rates and profit margins. The significant decline in stock value from a recent peak of $35.43 to approximately $18 underscores investor concerns about the company's ability to navigate these obstacles effectively.
This aggregate rating is based on analysts' research of Electromed and is not a guaranteed prediction by Public.com or investment advice.
Electromed (ELMD) Analyst Forecast & Price Prediction
Start investing in Electromed (ELMD)
Order type
Buy in
Order amount
Est. shares
0 shares